Qualify your xarelto lawsuit
Patients who’ve been hospitalized for internal bleeding while taking Xarelto may qualify for financial help from a lawsuit. Contact DrugNews today for more information or to speak with a lawyer.
Xarelto is a new-generation blood-thinning drug manufactured by German pharmaceutical giant Bayer. It was approved for use in the United States in 2011 and is sold in partnership with Johnson & Johnson.
Xarelto is similar to Eliquis and Pradaxa, among a class of anticoagulant drugs designed to replace warfarin. Unlike warfarin, it can be prescribed without regular blood tests or changes in diet. However, experts have warned it may carry greater risks for internal bleeding, since there is no reversal agent for emergencies.